IPX revenueFY2026$1.87M
- FY YoY
- -15.1%
IPX revenue was $1.87M for fiscal 2026 (ended Jun 30, 2026), down 15.1% from fiscal 2025. It rose in 3 of the last 4 fiscal years.
For fiscal 2026 (ended Jun 30, 2026), IperionX Limited reported $1.87M of revenue and -$66.77M of net income.
IPX revenue was $1.87M for fiscal 2026 (ended Jun 30, 2026), down 15.1% from fiscal 2025. It rose in 3 of the last 4 fiscal years.
IPX net income was -$66.77M for fiscal 2026 (ended Jun 30, 2026), compared with -$35.35M in fiscal 2025.
IPX diluted EPS was -$0.20 for fiscal 2026 (ended Jun 30, 2026), compared with -$0.12 in fiscal 2025.
IPX free cash flow was -$62.74M for fiscal 2026 (ended Jun 30, 2026), compared with -$38.76M in fiscal 2025.
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $1.87M | $2.20M | $546.0K | $139.7K | $24.0K |
| Research and development | $25.19M | $12.75M | $8.71M | $5.60M | $1.08M |
| Selling, general and admin | $25.92M | $10.69M | $4.52M | $3.99M | $3.06M |
| Interest expense | $311.7K | $279.5K | $122.7K | $88.1K | $45.5K |
| Pre-tax income | -$66.77M | -$35.35M | -$21.84M | -$17.44M | -$21.52M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$66.77M | -$35.35M | -$21.84M | -$17.44M | -$21.52M |
| EPS, basic | -$0.20 | -$0.12 | -$0.10 | -$0.11 | -$0.16 |
| EPS, diluted | -$0.20 | -$0.12 | -$0.10 | -$0.11 | -$0.16 |
| Diluted shares | 335.7M | 296.9M | 217.8M | 168.0M | 134.6M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | $35.24M | $54.81M | $33.16M | $11.94M | $5.67M |
| Receivables | $3.28M | $823.3K | $2.30M | $228.4K | $22.5K |
| Inventory | $3.91M | $0 | $16.9K | $0 | - |
| Current assets | $43.97M | $58.88M | $41.55M | $12.75M | $5.84M |
| Total assets | $105.75M | $105.03M | $55.44M | $22.80M | $9.91M |
| Current liabilities | $13.59M | $8.43M | $3.05M | $1.65M | $2.08M |
| Long-term debt | $3.53M | $3.46M | $1.04M | $592.7K | $408.8K |
| Total debt | $3.53M | $3.46M | $1.04M | $592.7K | $408.8K |
| Total liabilities | $17.45M | $12.59M | $4.10M | $2.24M | $2.49M |
| Shareholders' equity | $88.30M | $92.44M | $51.34M | $20.56M | $7.42M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$44.95M | -$21.80M | -$18.61M | -$15.86M | -$12.13M |
| Capital expenditures | $17.78M | $16.96M | $5.02M | $2.08M | $890.0K |
| Free cash flow | -$62.74M | -$38.76M | -$23.63M | -$17.94M | -$13.02M |
| Investing cash flow | -$18.56M | -$24.28M | -$6.53M | -$5.71M | -$3.07M |
| Financing cash flow | $43.18M | $67.99M | $46.59M | $27.89M | $19.39M |
| Stock-based compensation | $9.17M | $9.57M | $3.79M | $2.59M | $8.34M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue growth, YoY | -15.1% | 303.5% | 290.9% | 481.1% | - |
| Net margin | -3568.0% | -1604.4% | -4000.5% | -12487.6% | -89515.2% |
| Free cash flow margin | -3352.5% | -1759.3% | -4326.7% | -12843.6% | -54172.1% |
| Return on equity | -75.6% | -38.2% | -42.5% | -84.8% | -290.1% |
| Return on assets | -63.1% | -33.7% | -39.4% | -76.5% | -217.2% |
| Current ratio | 3.24 | 6.99 | 13.62 | 7.74 | 2.81 |
| Debt to equity | 0.04 | 0.04 | 0.02 | 0.03 | 0.06 |
Source: XBRL data IperionX Limited files with the SEC, latest filing dated Sep 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| IPX | $1.87M | -15.1% | -$66.77M | -3568.0% | $478.4M |
| CCJ | C$3.48B | +11.0% | C$589.58M | 16.9% | $31.05B |
| NXE | - | - | -C$309.68M | - | $5.53B |
| UEC | $37.25M | -44.3% | -$137.31M | -368.6% | $3.43B |
| ALM | C$32.51M | +12.8% | -C$161.91M | -498.0% | $2.34B |
| DNN | C$4.92M | +22.2% | -C$217.29M | -4418.2% | $1.98B |
| NMG | C$3.04M | -15.9% | -C$105.18M | -3462.0% | $274.9M |
| EU | $55.25M | +24.1% | -$65.22M | -118.1% | $122.1M |